(Q46826194)

25 December 2017

title

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia (English)

1 reference

25 December 2017

methicillin-resistant Staphylococcus aureus

main subject

0 references

vancomycin

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

1 reference

25 December 2017

author name string

Francesc Marco

1 reference

25 December 2017

José A Martínez

1 reference

25 December 2017

Elena Pisos

1 reference

25 December 2017

Manel Almela

1 reference

25 December 2017

Veselka P Dimova

1 reference

25 December 2017

Dolores Alamo

1 reference

25 December 2017

Mar Ortega

1 reference

25 December 2017

Josefina Lopez

1 reference

25 December 2017

Josep Mensa

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

25 December 2017

Clinical Infectious Diseases

published in

1 reference

25 December 2017

volume

1 reference

25 December 2017

issue

1 reference

25 December 2017

page(s)

193-200

1 reference

25 December 2017

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

cites work

1 reference

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

21 January 2018

1 reference

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

21 January 2018

1 reference

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

21 January 2018

1 reference

Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

21 January 2018

1 reference

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

21 January 2018

1 reference

[Antimicrobial resistance surveillance: VIRA STUDY 2006].

21 January 2018

1 reference

Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.

21 January 2018

1 reference

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides

21 January 2018

1 reference

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study

21 January 2018

1 reference

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

21 January 2018

1 reference

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

21 January 2018

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections

21 January 2018

1 reference

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

21 January 2018

1 reference

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia

21 January 2018

1 reference

Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

21 January 2018

1 reference

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

21 January 2018

1 reference

Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds

21 January 2018

1 reference

Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/524667

1 reference

25 December 2017

1 reference

25 December 2017